Prime Medicine, Inc.

Equities

Market Closed - Nasdaq Other stock markets 06:00:00 14/04/26 am AEST			5-day change	1st Jan Change
3.660 ^USD	+6.71%		+9.58%	+5.48%

19/03	Prime Medicine, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 02:15 PM
12/03	Oppenheimer Initiates Prime Medicine at Outperform With $11 Price Target	MT

Published on 12/20/2025 at 07:56 am AEDT - Modified on 12/20/2025 at 08:21 am AEDT

S&P Capital IQ

Presenter Speech
Unknown Analyst (Analysts)

Thank you, guys, for being here. Super excited to have an old friend join us for a new fireside chat.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

19/03	Prime Medicine, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 02:15 PM
12/03	Oppenheimer Initiates Prime Medicine at Outperform With $11 Price Target	MT
07/03	Prime Medicine, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-04-2026 01:10 PM
04/03	Prime Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04/03	Prime Medicine 2025 Net Loss Narrows as Revenue Rises -- Shares Fall Pre-Bell	MT
04/03	Earnings Flash (PRME) Prime Medicine Posts 2025 Total Revenue $4.6M, vs. FactSet Est of $5.7M	MT
04/03	Earnings Flash (PRME) Prime Medicine Posts 2025 Net Loss $1.35 a Share, vs. FactSet Est of $1.30 Loss	MT
03/03	Prime Medicine, Inc. Auditor Raises 'Going Concern' Doubt	CI
15/01	Prime Medicine, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:00 AM
24/12	LifeSci Initiates Prime Medicine at Outperform With $6 Price Target	MT
22/12	Prime Medicine, Inc.(NasdaqGM:PRME) added to S&P Biotechnology Select Industry Index	CI
20/12	Prime Medicine, Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 11:15 AM
08/12	Prime Medicine Announces the New England Journal of Medicine Publication of Pm359 Clinical Data for the Treatment of Chronic Granulomatous Disease	CI
13/11	Prime Medicine, Inc. - Special Call
07/11	Prime Medicine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI